These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 24726263)

  • 1. Role of lymphovascular invasion and immunohistochemical expression of IMP3 in the risk stratification of superficially invasive pT1 esophageal adenocarcinoma.
    Trivedi A; Cartun RW; Ligato S
    Pathol Res Pract; 2014 Jul; 210(7):402-6. PubMed ID: 24726263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of insulin-like growth factor II mRNA-binding protein 3 (IMP3) has negative prognostic impact on early invasive (pT1) adenocarcinoma of the esophagus.
    Plum PS; Ulase D; Bollschweiler E; Chon SH; Berlth F; Zander T; Alakus H; Hölscher AH; Bruns CJ; Schallenberg S; Quaas A; Loeser H
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1731-1739. PubMed ID: 29974234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duplicated muscularis mucosae invasion has similar risk of lymph node metastasis and recurrence-free survival as intramucosal esophageal adenocarcinoma.
    Estrella JS; Hofstetter WL; Correa AM; Swisher SG; Ajani JA; Lee JH; Bhutani MS; Abraham SC; Rashid A; Maru DM
    Am J Surg Pathol; 2011 Jul; 35(7):1045-53. PubMed ID: 21602659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma.
    Cen P; Hofstetter WL; Correa AM; Wu TT; Lee JH; Ross WA; Davilla M; Swisher SG; Fukami N; Rashid A; Maru D; Ajani JA
    Cancer; 2008 Mar; 112(5):1020-7. PubMed ID: 18205187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Budding as a risk factor for lymph node metastasis in pT1 or pT2 well-differentiated colorectal adenocarcinoma.
    Okuyama T; Oya M; Ishikawa H
    Dis Colon Rectum; 2002 May; 45(5):628-34. PubMed ID: 12004212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Immunostaining for the diagnosis of Lymphovascular invasion in superficial Barrett's esophageal adenocarcinoma.
    Hosono I; Miyahara R; Furukawa K; Funasaka K; Sawada T; Maeda K; Yamamura T; Ishikawa T; Ohno E; Nakamura M; Kawashima H; Yokoi T; Tsukamoto T; Hirooka Y; Fujishiro M
    BMC Gastroenterol; 2020 Jun; 20(1):175. PubMed ID: 32503448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of lymphovascular invasion in patients with esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy.
    Chen WH; Huang YL; Chao YK; Yeh CJ; Chang HK; Tseng CK; Liu YH
    Ann Surg Oncol; 2015 Jan; 22(1):338-43. PubMed ID: 25023545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical Management of Early-Stage Esophageal Adenocarcinoma Based on Lymph Node Metastasis Risk.
    Newton AD; Predina JD; Xia L; Roses RE; Karakousis GC; Dempsey DT; Williams NN; Kucharczuk JC; Singhal S
    Ann Surg Oncol; 2018 Jan; 25(1):318-325. PubMed ID: 29147928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of lymphovascular invasion in lymph node-negative superficial esophageal squamous cell carcinoma.
    Oguma J; Ozawa S; Kazuno A; Yamamoto M; Ninomiya Y; Yatabe K; Makuuchi H; Ogura G
    Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30883635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ANPEP/CD13 Expression as a Marker of Lymphovascular Invasion and Survival in Esophageal Adenocarcinoma.
    Goltsov AA; Maru DM; Katkhuda R; Duose DY; Luthra R; Correa AM; Wang F; Futreal PA; Hofstetter WL
    Ann Thorac Surg; 2024 Jul; 118(1):241-251. PubMed ID: 37806335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of lymph node metastasis in T1 esophageal adenocarcinoma: a meta-analysis.
    Nguyen CL; Tovmassian D; Isaacs A; Falk GL
    Dis Esophagus; 2024 Jun; 37(6):. PubMed ID: 38391209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of insulin-like growth factor II mRNA-binding protein 3 (IMP3) as a new marker for the diagnosis of esophageal adenocarcinoma in challenging cases.
    Kazeminezhad B; Mirafsharieh SA; Dinyari K; Azizi D; Ebrahimi A
    Turk J Gastroenterol; 2014 Jun; 25(3):253-6. PubMed ID: 25141312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphovascular invasion and nodal metastasis in intramucosal adenocarcinoma of the esophagus and esophagogastric junction.
    Li ZG; Zhu H; Shi H; Xie H; Goldblum JR; Thota PN; Liu X
    J Dig Dis; 2015 Apr; 16(4):197-204. PubMed ID: 25620066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early-stage adenocarcinoma of the esophagus with mid to deep submucosal invasion (pT1b sm2-3): the frequency of lymph-node metastasis depends on macroscopic and histological risk patterns.
    Manner H; Wetzka J; May A; Pauthner M; Pech O; Fisseler-Eckhoff A; Stolte M; Vieth M; Lorenz D; Ell C
    Dis Esophagus; 2017 Feb; 30(3):1-11. PubMed ID: 26952572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of endoscopic resection in superficial esophageal squamous carcinoma.
    Choi JY; Park YS; Jung HY; Ahn JY; Kim MY; Lee JH; Choi KS; Kim DH; Choi KD; Song HJ; Lee GH; Cho KJ; Kim JH
    Gastrointest Endosc; 2011 May; 73(5):881-9, 889.e1-2. PubMed ID: 21392755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease.
    Schölvinck D; Künzli H; Meijer S; Seldenrijk K; van Berge Henegouwen M; Bergman J; Weusten B
    Surg Endosc; 2016 Sep; 30(9):4102-13. PubMed ID: 27357927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management and long-term outcomes of endoscopic and surgical treatment of early esophageal adenocarcinoma.
    Saunders JH; Al-Zubaidi S; Waller RC; Ortiz-Fernandez-Sordo J; Parsons SL; Ragunath K; Kaye PV;
    Dis Esophagus; 2020 Sep; 33(9):. PubMed ID: 32090253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive lymph node dissection may be necessary in minute submucosal cancer of the stomach after endoscopic resection.
    Kim JH; Lee YC; Kim H; Yoon SO; Kim H; Youn YH; Park H; Lee SI; Choi SH; Noh SH
    Ann Surg Oncol; 2012 Mar; 19(3):779-85. PubMed ID: 21964889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inter-Observer Variability in the Interpretation of Endoscopic Mucosal Resection Specimens of Esophageal Adenocarcinoma: Interpretation of ER specimens.
    Worrell SG; Boys JA; Chandrasoma P; Vallone JG; Dunst CM; Johnson CS; Lada MJ; Louie BE; Watson TJ; DeMeester SR
    J Gastrointest Surg; 2016 Jan; 20(1):140-4; discussion 144-5. PubMed ID: 26503261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular markers predicting lymph node metastasis in early esophageal cancer.
    Plum PS; Warnecke-Eberz U; Dhaouadi O; Alakus H; Drebber U; Metzger R; Prenzel KL; Hölscher AH; Bollschweiler E
    Histol Histopathol; 2015 Oct; 30(10):1193-202. PubMed ID: 25869644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.